Skip to main content
Top
Published in: Clinical Rheumatology 10/2007

01-10-2007 | Case Report

Henoch–Schönlein purpura nephritis complicated by reversible posterior leukoencephalopathy syndrome

Authors: Daimei Sasayama, Yasuhiro Shimojima, Takahisa Gono, Kazuma Kaneko, Masayuki Matsuda, Shu-ichi Ikeda

Published in: Clinical Rheumatology | Issue 10/2007

Login to get access

Abstract

We report a young female patient with Henoch–Schönlein purpura (HSP) nephritis complicated by reversible posterior leukoencephalopathy syndrome (RPLS). The patient suddenly showed generalized seizures and cortical blindness with severe hypertension due to renal insufficiency approximately 1 year after cessation of corticosteroid treatment for HSP nephritis. Magnetic resonance imaging (MRI) demonstrated bilateral abnormal signals mainly in the cerebellum and white matter of the occipital lobe. Clinical symptoms quickly improved in conjunction with disappearance of abnormal signals on brain MRI after starting control of hypertension and continuous hemodiafiltration with steroid pulse therapy and plasmapheresis. RPLS may be caused by vasculitis and also by hemodynamic change due to severe hypertension in HSP, particularly in patients with nephropathy. In such cases intensive treatment should be performed as soon as possible to avoid neurological sequelae.
Literature
1.
go back to reference Brogan PA, Dillon MJ (2000) Vasculitis from the pediatric perspective. Curr Rheumatol Rep 2:411–416PubMedCrossRef Brogan PA, Dillon MJ (2000) Vasculitis from the pediatric perspective. Curr Rheumatol Rep 2:411–416PubMedCrossRef
2.
go back to reference Belman AL, Leicher CR, Moshe SL, Mezey AP (1985) Neurologic manifestations of Schönlein–Henoch purpura: report of three cases and review of the literature. Pediatrics 75:687–692PubMed Belman AL, Leicher CR, Moshe SL, Mezey AP (1985) Neurologic manifestations of Schönlein–Henoch purpura: report of three cases and review of the literature. Pediatrics 75:687–692PubMed
3.
go back to reference Ha TS, Cha SH (1996) Cerebral vasculitis in Henoch–Schönlein purpura: a case report with sequential magnetic resonance imaging. Pediatr Nephrol 10:634–636PubMedCrossRef Ha TS, Cha SH (1996) Cerebral vasculitis in Henoch–Schönlein purpura: a case report with sequential magnetic resonance imaging. Pediatr Nephrol 10:634–636PubMedCrossRef
4.
go back to reference Woolfenden AR, Hukin J, Poskitt KJ, Connolly MB (1998) Encephalopathy complicating Henoch–Schönlein purpura: reversible MRI changes. Pediatr Neurol 19:74–77PubMedCrossRef Woolfenden AR, Hukin J, Poskitt KJ, Connolly MB (1998) Encephalopathy complicating Henoch–Schönlein purpura: reversible MRI changes. Pediatr Neurol 19:74–77PubMedCrossRef
5.
go back to reference Perez C, Maravi E, Olier J, Guarch R (2000) MR imaging of encephalopathy in adult Henoch–Schönlein purpura. Am J Roentgenol 175:922–923 Perez C, Maravi E, Olier J, Guarch R (2000) MR imaging of encephalopathy in adult Henoch–Schönlein purpura. Am J Roentgenol 175:922–923
6.
go back to reference Bakkaloglu SA, Ekim M, Tumer N, Deda G, Erden I, Erdem T (2000) Cerebral vasculitis in Henoch–Schönlein purpura. Nephrol Dial Transplant 15:246–248PubMedCrossRef Bakkaloglu SA, Ekim M, Tumer N, Deda G, Erden I, Erdem T (2000) Cerebral vasculitis in Henoch–Schönlein purpura. Nephrol Dial Transplant 15:246–248PubMedCrossRef
7.
go back to reference Chen CL, Chiou YH, Wu CY, Lai PH, Chung HM (2000) Cerebral vasculitis in Henoch–Schönlein purpura: a case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatr Nephrol 15:276–278PubMedCrossRef Chen CL, Chiou YH, Wu CY, Lai PH, Chung HM (2000) Cerebral vasculitis in Henoch–Schönlein purpura: a case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatr Nephrol 15:276–278PubMedCrossRef
8.
go back to reference Eun SH, Kim SJ, Cho DS, Chung GH, Lee DY, Hwang PH (2003) Cerebral vasculitis in Henoch–Schönlein purpura: MRI and MRA findings, treated with plasmapheresis alone. Pediatr Int 45:484–487PubMedCrossRef Eun SH, Kim SJ, Cho DS, Chung GH, Lee DY, Hwang PH (2003) Cerebral vasculitis in Henoch–Schönlein purpura: MRI and MRA findings, treated with plasmapheresis alone. Pediatr Int 45:484–487PubMedCrossRef
9.
go back to reference Ozcakar BZ, Ekim M, Fitoz S, Teber S, Hizel S, Acar B et al (2004) Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 163:728–730PubMedCrossRef Ozcakar BZ, Ekim M, Fitoz S, Teber S, Hizel S, Acar B et al (2004) Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 163:728–730PubMedCrossRef
10.
go back to reference Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedCrossRef Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedCrossRef
11.
go back to reference Counahan R, Winterborn MH, White RHR, Heaton JM, Meadow SR, Bluett NH et al (1977) Prognosis of Henoch–Schönlein nephritis in children. Br Med J 2:11–14PubMedCrossRef Counahan R, Winterborn MH, White RHR, Heaton JM, Meadow SR, Bluett NH et al (1977) Prognosis of Henoch–Schönlein nephritis in children. Br Med J 2:11–14PubMedCrossRef
12.
go back to reference Ahn KJ, You WJ, Jeong SL, Lee JW, Kim BS, Lee JH et al (2004) Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology (Epub ahead of print) Ahn KJ, You WJ, Jeong SL, Lee JW, Kim BS, Lee JH et al (2004) Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology (Epub ahead of print)
13.
go back to reference Kumai Y, Toyoda K, Fujii K, Ibayashi S (2002) Hypertensive encephalopathy extending into the whole brainstem and deep structures. Hypertens Res 25:797–800PubMedCrossRef Kumai Y, Toyoda K, Fujii K, Ibayashi S (2002) Hypertensive encephalopathy extending into the whole brainstem and deep structures. Hypertens Res 25:797–800PubMedCrossRef
14.
go back to reference Calabresi P, Pisani A, Mercuri NB, Bernardi G (1995) On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. Brain 118:1027–1038PubMedCrossRef Calabresi P, Pisani A, Mercuri NB, Bernardi G (1995) On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. Brain 118:1027–1038PubMedCrossRef
15.
16.
go back to reference Edvinsson L, Owman C, Sjoberg NO (1976) Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 115:377–393PubMedCrossRef Edvinsson L, Owman C, Sjoberg NO (1976) Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 115:377–393PubMedCrossRef
Metadata
Title
Henoch–Schönlein purpura nephritis complicated by reversible posterior leukoencephalopathy syndrome
Authors
Daimei Sasayama
Yasuhiro Shimojima
Takahisa Gono
Kazuma Kaneko
Masayuki Matsuda
Shu-ichi Ikeda
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 10/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0502-0

Other articles of this Issue 10/2007

Clinical Rheumatology 10/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine